| Name | Title | Contact Details |
|---|---|---|
Christopher Blanchette |
Vice President and Head, Clinical Development and Outcomes Research, NNI | Profile |
John McDonald |
Corporate Vice President, Global R&D Business Development | Profile |
Jill Branca Priselac |
VP, R&D Business Development | Profile |
Benjamin Soule |
Senior Medical Director, NASH - Clinical Development and Research, NNI | Profile |
Rahul Ganguly |
Vice President, Clinical Development & Outcomes Research | Profile |
Novartis provides healthcare solutions that improve and extend people`s lives. We use science-based innovation to address some of society`s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. Our company is focused on industry-leading divisions with innovation power and global scale: pharmaceuticals, eye care and generic medicines Novartis is headquartered in Basel, Switzerland. Novartis Group companies employ approximately 120,000 associates and its products are available in more than 180 countries around the world.
Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 140-year-old global pharmaceutical company with headquarters in Osaka, Japan. In the U.S., Shionogi Inc. leverages our science-based heritage to develop and commercialize pharmaceutical products to treat unmet medical needs in our core areas of infectious diseases and pain, as well as other areas of high medical need, including chronic liver disease.
BONESUPPORT AB is a Scandinavian orthobiologics company that develops and markets CERAMENT®, an innovative range of radiopaque injectable osteoconductive and drug-eluting bioceramic products that have a proven ability to heal defects by remodeling to h...
Medical Technology Systems, Inc. is a Saint Petersburg, FL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.